| 股票 | 申万二级 | PE | 前瞻PE | PEG | PB | 股息率 | 分红率 | 毛利率 | 固定资产 | 债/EBITDA | FCF/市值 | 营收3年 | 去年 | YTD | 近一年 | 回撤 | 波动 | 市值亿 ▴ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 广济药业 000952 | 化学制药 | — | — | — | 3.70 | — | — | 27% | 51% | 77.7 | 2.8% | -8% | +14% | -8% | -6% | -51% | 48% | 22 |
| 东亚药业 605177 | 化学制药 | — | — | — | 1.58 | — | 30% | 27% | 59% | 27.9 | -1.0% | -7% | -10% | +23% | +5% | -40% | 43% | 25 |
| 赛托生物 300583 | 化学制药 | 263.0 | — | — | 1.46 | 0.1% | 180% | 21% | 48% | 3.1 | 4.9% | -8% | -30% | -1% | -25% | -39% | 36% | 26 |
| 溢多利 300381 | 化学制药 | — | — | — | 1.06 | 0.9% | 158% | 44% | 50% | 0.3 | -5.3% | -11% | -6% | -14% | -28% | -30% | 35% | 27 |
| 共同药业 300966 | 化学制药 | — | 118.0 | 1.18 | 3.90 | 0.2% | 8% | 22% | 64% | 17.2 | -0.6% | +0% | +22% | +20% | +1% | -31% | 43% | 27 |
| 拓新药业 301089 | 化学制药 | — | — | — | 1.98 | — | 13% | 38% | 51% | — | -2.3% | -22% | -1% | -18% | -35% | -42% | 41% | 29 |
| ST能特 002102 | 化学制药 | — | — | — | 1.94 | — | — | 3% | 15% | 5.4 | -17.7% | -16% | +27% | -27% | -43% | -55% | 37% | 58 |
| 尔康制药 300267 | 化学制药 | — | — | — | 1.66 | — | — | 23% | 43% | 4.9 | -2.0% | -15% | +23% | -5% | -21% | -40% | 50% | 67 |
| 海翔药业 002099 | 化学制药 | — | — | — | 1.83 | — | — | 27% | 39% | 8.4 | -1.0% | -12% | +21% | -13% | -10% | -44% | 47% | 88 |
点表头排序。市值单位亿元;去年/YTD 为前复权涨幅;债/EBITDA = 有息负债 ÷ EBITDA。